article thumbnail

Hidden compliance risks for life sciences companies

pharmaphorum

The life sciences history industry has some unique challenges when it comes to compliance. Early life science pioneers in foreign markets earned a reputation for lax ethical behaviour, making them a prime target for regulators. In 2020, life science firms accounted for a third of the SEC’s enforcement actions.

article thumbnail

Celebrating Black History Month: Black Scientists that Have Revolutionized the Life Sciences

XTalks

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. This invention made it possible to remove cataracts more safely and quickly, significantly improving vision restoration techniques.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IWD: Spotlight on women in life sciences

pharmaphorum

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been? Ultimately, this has to start at school.

article thumbnail

Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy – Xtalks Life Science Podcast Ep. 163

XTalks

Dr. McLeod received his Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science and completed his Post-Doctoral Training at St Jude Children’s Research Hospital and the University of Glasgow. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Theranos’ Elizabeth Holmes Wants New Trial: What Life Science Startups Can Learn from Her Case

XTalks

In January 2022, Holmes was found guilty of multiple counts of fraud in a federal trial where it was revealed that she had misled investors, patients and doctors about the capabilities of her company’s blood testing technology. Life science startups face unique challenges given the highly regulated and complex nature of the industry.

article thumbnail

Consumers want convenient, online doctor-finding tools

pharmaphorum

When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients. That number is up 17% from 2019.

Doctors 98
article thumbnail

What comes next: digital transformation in B2B life sciences sales

pharmaphorum

As the contours of a post-pandemic world begin to take shape, those working B2B sales in the life sciences acknowledge that the industry must adapt to some permanent shifts. In certain subsectors, decisions are still made in the hospital and doctors’ offices among prospects who have little time, but nevertheless expect clinical depth.